ASBP · Aspire Biopharma Holdings, Inc.
$8.87
-0.38 (-4.11%)
At close · Sep 4
View the 10-Q filed Aug 13, 2026
Customer concentration
— top customer 15% of revenue
One customer — 15% of revenue (the six months ended June 30, 2026)
“One customer accounted for approximately 15% of the Company’s total revenues during the six months ended June 30, 2026.”
Market Cap
$12.44M
Shares
1.40M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding ASBP
5 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | FSMAX | 1,029 | $5,649 | 0.00% | Long | 2026-05-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 263 | $1,404 | 0.00% | Long | 2026-06-30 | |
| Fidelity Series Total Market Index Fund | FCFMX | 81 | $445 | 0.00% | Long | 2026-05-31 | |
| Fidelity Total Market Index Fund | FSKAX | 47 | $258 | 0.00% | Long | 2026-05-31 | |
| Blackstone Alternative Multi-Strategy Fund | — | 1 | $5 | 0.00% | Long | 2026-06-30 |
Showing 1–5 of 5 positions